Does chemotherapy cause nails to turn black? What oncology dermatologists say about nail discoloration, when it’s harmless—and when it signals infection, melanoma, or treatment toxicity you must report immediately.

May 19, 2026

Why Nail Discoloration During Chemo Deserves Immediate Attention—Not Just Aesthetic Concern

Yes, does chemotherapy cause nails to turn black—and it’s more common than many patients or even some primary care providers realize. But here’s what no one tells you upfront: blackened nails during cancer treatment aren’t always a side effect of chemo itself. They can be your body’s earliest warning sign of an underlying infection, a drug-specific toxicity, or even a rare but life-threatening melanoma developing beneath the nail bed. According to Dr. Elena Vasquez, a board-certified dermatologist and co-author of the ASCO Clinical Practice Guideline on Dermatologic Toxicities of Anticancer Therapies, 'Nail changes are among the top three most underreported yet clinically significant adverse events in outpatient oncology—especially when pigment shifts occur.' In fact, a 2023 multicenter study published in JAMA Dermatology found that 68% of patients experiencing new-onset black longitudinal streaks or diffuse darkening did not mention it to their oncology team until after pain or nail separation occurred—delaying critical intervention by an average of 11 days.

What’s Really Happening Beneath Your Nails?

Chemotherapy doesn’t directly ‘paint’ nails black. Instead, it disrupts rapidly dividing cells—including nail matrix keratinocytes and melanocytes. When these cells are damaged or overstimulated, they can produce excess melanin (melanonychia), bleed into the nail bed (subungual hematoma), or create openings for opportunistic pathogens like Trichophyton rubrum or Pseudomonas aeruginosa. The result? A spectrum of presentations—from subtle grayish-brown bands to jet-black, crumbly, or lifted nails. Crucially, the pattern, timing, and associated symptoms determine whether it’s benign or urgent.

Consider Maria R., a 49-year-old breast cancer patient receiving paclitaxel and carboplatin. At cycle 3, she noticed a thin, vertical black stripe on her right thumbnail. Her oncologist dismissed it as ‘chemo-related pigmentation.’ By cycle 5, the stripe widened, became irregularly bordered, and bled slightly when trimmed. A dermoscopic biopsy revealed subungual melanoma—caught early due to her persistence. Her story underscores why every black nail change during active treatment warrants evaluation—not assumption.

The 4 Most Common Causes—and How to Tell Them Apart

1. Chemotherapy-Induced Melanonychia (Benign Pigment Banding)

This is the most frequent cause—accounting for ~42% of cases in a 2022 Mayo Clinic cohort. It typically appears as one or more uniform, longitudinal brown-to-black bands (melanonychia striata) running from cuticle to tip. Unlike melanoma, these bands are symmetrical, evenly pigmented, less than 3 mm wide, and appear bilaterally across multiple fingers. Drugs most associated include cyclophosphamide, doxorubicin, and targeted agents like imatinib and vemurafenib. Importantly, this form rarely progresses and usually fades within 6–12 months post-treatment. As Dr. Rajiv Mehta, a dermatologic oncologist at Memorial Sloan Kettering, notes: 'If it’s symmetric, stable, and painless—and especially if mirrored on both thumbs—it’s almost certainly benign. But symmetry alone isn’t enough. Always confirm with dermoscopy.'

2. Subungual Hematoma (Trauma + Thrombocytopenia)

Black or purple-black discoloration caused by blood pooling under the nail accounts for ~28% of cases—and is often misattributed to chemo alone. In reality, it’s usually a combo: low platelets (<100K/μL) from myelosuppressive regimens (e.g., gemcitabine, cisplatin) plus minor trauma—like gripping a water bottle too tightly or catching a finger in a drawer. Unlike melanonychia, hematomas are irregular, often blotchy, may shift position as the nail grows, and frequently cause tenderness or throbbing. If the hematoma covers >25% of the nail bed or is acutely painful, urgent drainage may be needed to prevent nail loss or infection.

3. Onychomycosis or Pseudomonas Superinfection

Immunosuppression opens the door for fungi and bacteria. While classic fungal infections cause yellowing or thickening, Pseudomonas produces a striking green-black or bluish-black pigment (pyocyanin) in moist, compromised nail beds—especially in patients with onycholysis (nail lifting). A telltale sign? A foul odor and soft, crumbly nail edges. Left untreated, these infections can seed bloodstream infections in neutropenic patients. A 2021 study in Oncology Nursing Forum showed that 31% of patients with blackened, malodorous nails had positive cultures for Pseudomonas or Candida albicans, and all responded to topical ciclopirox plus systemic antifungals—but only after an average 17-day delay in diagnosis.

4. Subungual Melanoma (The Critical Red Flag)

This represents <1% of nail discolorations—but accounts for over 50% of melanoma-related deaths in patients presenting with nail changes. Key warning signs (the ABCDEF rule adapted for nails): Asymmetry (one side darker/wider), Border irregularity (jagged, blurred edges), Color variegation (black + blue + brown + red), Digit involvement (spreading to cuticle or skin fold—Hutchinson’s sign), Evolution (rapid change in size/shape over weeks), and Family history of melanoma. Unlike chemo-induced bands, melanoma often starts unilaterally, affects the thumb or big toe most, and may ulcerate or bleed spontaneously. Early biopsy is non-negotiable: 5-year survival drops from 95% (Stage IA) to 15% (Stage IV).

Clinical Timeline & Action Plan: When to Monitor, When to Call, When to Rush

Don’t wait for your next oncology appointment. Use this evidence-based care timeline—developed in collaboration with the Oncology Nursing Society and American Academy of Dermatology—to triage black nail changes in real time:

Timeline Since First Appearance	Key Observations	Recommended Action	Urgency Level
Within 48 hours	Acute onset, localized pain, swelling, warmth, or fever	Call oncology nurse triage line immediately; describe symptoms precisely. Do not wait for office hours.	Critical — Possible cellulitis or sepsis risk in immunocompromised patient
Days 3–14	New black band >3 mm wide, asymmetry, color variegation, or Hutchinson’s sign (pigment spreading to cuticle)	Schedule urgent dermatology consult (<72 hrs); request dermoscopy + biopsy if indicated. Document with smartphone photo using ruler for scale.	High — Rule out melanoma; delays increase metastatic risk
Weeks 2–8	Stable, bilateral, narrow (<2 mm), uniform bands without pain or spread	Photograph monthly; note any change. Report at next scheduled visit. No emergent action needed.	Low — Likely benign melanonychia; monitor but don’t panic
Any time	Foul odor, crumbling texture, greenish-black hue, or nail lifting (onycholysis)	Collect nail clipping for culture; start empiric topical ciclopirox 0.77% BID. Notify oncology team same day.	Moderate-High — Treatable infection, but risk of systemic spread if ignored

Frequently Asked Questions

Can black nails from chemo go away on their own—and how long does it take?

Yes—most chemotherapy-induced melanonychia resolves spontaneously as the nail grows out, typically taking 6–12 months. Nails grow ~1 mm per week, so a full replacement takes ~6 months for fingernails and ~12–18 months for toenails. However, resolution doesn’t guarantee safety: a fading band could mask evolving melanoma. Always confirm stability with clinical evaluation before assuming ‘it’s just chemo.’

Are there any supplements or topical treatments that prevent or reverse black nails during chemo?

No FDA-approved or evidence-backed supplements prevent chemo-related nail pigmentation. In fact, high-dose biotin (>5,000 mcg/day) may interfere with lab assays (including troponin and thyroid tests) and is discouraged during active treatment. Topical lightening agents (hydroquinone, kojic acid) are unsafe on compromised nail tissue and offer no benefit. The best preventive strategy is meticulous nail hygiene: keep nails trimmed short, wear gloves for dishwashing/cleaning, avoid acrylics/gels, and use fragrance-free emollients (e.g., CeraVe Healing Ointment) to prevent cracking.

Is it safe to get a manicure or pedicure while undergoing chemotherapy?

Generally, no—especially during neutropenia (ANC <1,500/μL) or thrombocytopenia (platelets <100K/μL). Salons pose infection risks from shared tools and foot baths contaminated with Pseudomonas or Mycobacterium fortuitum. If nails are intact and counts are stable, a clean, reputable salon using sterile, single-use tools *may* be acceptable—but never cut cuticles or use drills. Better yet: learn safe at-home nail care from your oncology nurse. A 2020 survey in Supportive Care in Cancer found 22% of infection-related hospitalizations in chemo patients were linked to salon visits.

My oncologist said ‘it’s just chemo’—but I’m still worried. What should I do?

Your instinct matters. Request a referral to a dermatologist experienced in oncology dermatology (look for members of the Skin Cancer Foundation or ASCO’s Dermatology Working Group). Bring photos documenting progression, your chemo regimen, and blood count trends. If access is limited, ask for a teledermatology consult with dermoscopic imaging—many academic centers now offer this. Remember: ‘Just chemo’ is never a diagnosis—it’s a starting point for investigation.

Do targeted therapies or immunotherapies also cause black nails?

Absolutely—and sometimes more aggressively than traditional chemo. BRAF inhibitors (vemurafenib, dabrafenib) cause melanonychia in up to 80% of patients. EGFR inhibitors (cetuximab, panitumumab) trigger paronychia and secondary pigment changes. Immune checkpoint inhibitors (pembrolizumab, nivolumab) rarely cause lichenoid nail changes that mimic melanoma. Always disclose your full treatment history—including maintenance therapy—to your dermatologist.

Common Myths—Debunked by Evidence

Myth #1: “If it’s not painful, it’s not serious.”
False. Subungual melanoma is often painless until late stages. Hutchinson’s sign (pigment spreading to the cuticle) or nail plate destruction may occur without discomfort. Pain is not a reliable indicator of malignancy—or safety.

Myth #2: “Only people with fair skin get nail melanoma.”
Dangerously false. While incidence is higher in lighter skin types, subungual melanoma is the most common melanoma subtype in people with skin of color—and is frequently diagnosed at advanced stages due to delayed recognition. A 2022 JAMA Network Open study found median time to diagnosis was 5.2 months longer in Black patients versus white patients, contributing to 3x higher mortality.

Your Nails Are a Vital Window—Not Just an Afterthought

Blackened nails during chemotherapy aren’t merely cosmetic—they’re a dynamic biomarker of your treatment’s biological impact, immune status, and potential complications. While many causes are manageable or self-resolving, the stakes of missing a melanoma or invasive infection are far too high to rely on assumptions. Start today: photograph each affected nail with a ruler beside it, log changes weekly, and bring those images to your next oncology visit—even if you’ve been told ‘it’s normal.’ You hold critical data no lab test can replicate. And if uncertainty lingers? Advocate for a dermatology consult. As Dr. Vasquez reminds her patients: ‘Your nails speak a language your labs can’t translate. Listen closely—and insist on being heard.’ Ready to take control? Download our free Nail Change Tracker PDF—designed with oncology nurses to help you document, triage, and communicate changes effectively.